0      0


262 - System Wide Implementation of Intravesicular Administration of Medication to Treat Bladder Cancer - Current Practice Guidelines: SUNA/AUA joint paper


‐ Oct 28, 2023 3:10pm


Credits: None available.

Practice guidelines can assist clinicians in making decisions regarding appropriate healthcare for specific clinical situations to optimize quality of patient care and improve outcomes. Learn about the journey taken by a large, multi-state healthcare organization of standardizing the administration of intravesical medications for treatment of bladder cancer utilizing practice guidelines.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 10/29/25.

Requirements for Successful Completion:

Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:

There are no disclosures to declare.

Speaker Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the participant will be able to describe how a large, multi-state healthcare organization standardized the administration of intravesical medications for treatment of bladder cancer utilizing practice guidelines.


Speaker(s):

Credits Available


System Wide Implementation of Intravesicular Administration of Medication to Treat Bladder Cancer - Current Practice Guidelines: SUNA/AUA joint paper

You must be logged in and own this session in order to post comments.